MedPath

Clinical Study To Assess The Efficacy of Ayurvedic Formulations In PCOS

Phase 2
Conditions
Health Condition 1: N830- Follicular cyst of ovary
Registration Number
CTRI/2020/07/026410
Lead Sponsor
ational Institute of Ayurveda Jaipur
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients willing to give voluntary informed consent.

Both married and unmarried patients.

ASRM/ESHRE (Rotterdam) Criteria,2013- Affected individuals must have two out of three criteria

1. Oligo and /or anovulation

2. Hyperandrogenism (clinical and /or biochemical).

3. Polycystic ovaries(Confirmed on USG).

Exclusion Criteria

Patients not willing to give voluntary informed consent.

Women of age <18years and >40years.

Patients with chronic systemic illness (Congestive cardiac failure, Hypertension, cirrhosis of liver, chronic renal disease, diabetes mellitus, Tuberculosis etc.).

Patients using oral contraceptive pills.

Patients with any organic reproductive system abnormalities (Excluded clinically and radiologically), pelvic inflammatory disease, hydrosalpinx, endometriosis, adenomyosis, fibroid uterus, carcinoma of reproductive organ.

Any type of malignancy.

Patients with positive Sexually transmitted diseases (STDs), Human Immunodeficiency Virus HIV, Hepatitis B Surface Antigen(HbsAg).

Patients suffering from adrenal hyperplasia, severe insulin resistance, androgen secreting neoplasm, thyroid abnormalities, Cushingâ??s syndrome.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in features of oligomenorrhoea /anovulation.Timepoint: 3 months
Secondary Outcome Measures
NameTimeMethod
Changes in PCOS features (i.e. acne, hirsutism).Timepoint: 3 months
© Copyright 2025. All Rights Reserved by MedPath